This inventor holds 2 USPTO granted patents. Top assignees: Eli Lilly and Company, Other. Active years: 2001-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 4,514 
1 out of 834,513 Years Active: 2001-2004
Title: Inka Leier: Innovator in Tumor Resistance Treatment
Introduction
Inka Leier is a notable inventor based in Bammental, Germany. She has made significant contributions to the field of oncology, particularly in the area of tumor resistance. With a total of 2 patents, her work focuses on innovative methods for identifying and treating resistant tumors.
Latest Patents
Inka Leier's latest patents include groundbreaking methods for identifying and treating resistant tumors. One of her inventions provides a method of identifying and reversing multidrug resistance in a multidrug resistant tumor. This involves administering a multidrug resistance reversing amount of specific compounds. This innovative approach aims to enhance treatment efficacy for patients facing multidrug-resistant tumors.
Career Highlights
Throughout her career, Inka has worked with prominent companies, including Eli Lilly and Company. Her experience in the pharmaceutical industry has allowed her to develop and refine her inventions, contributing to advancements in cancer treatment.
Collaborations
Inka has collaborated with esteemed colleagues such as Dietrich Keppler and Gabriele Jedlitschky. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Inka Leier's contributions to the field of oncology through her patents and collaborations highlight her commitment to improving cancer treatment. Her innovative methods for addressing tumor resistance are paving the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile